Edition:
United Kingdom

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

72.18EUR
10:42am BST
Change (% chg)

€0.02 (+0.03%)
Prev Close
€72.16
Open
€71.69
Day's High
€72.24
Day's Low
€71.32
Volume
615,694
Avg. Vol
2,682,256
52-wk High
€86.39
52-wk Low
€62.88

Chart for

About

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality... (more)

Overall

Beta: 0.93
Market Cap(Mil.): €108,903.00
Shares Outstanding(Mil.): 1,262.50
Dividend: 2.96
Yield (%): 3.43

Financials

  SASY.PA Industry Sector
P/E (TTM): 23.32 30.93 32.76
EPS (TTM): 3.70 -- --
ROI: 5.69 15.07 14.61
ROE: 8.50 16.59 16.33

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance

FRANKFURT Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

6:32am BST

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance

FRANKFURT Pfizer has agreed to pay German biotech firm BioNTech up to $425 million (£334.33 million) in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

6:14am BST

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance

FRANKFURT, Aug 16 Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

6:00am BST

Amicus Therapeutics receives U.S. approval for Fabry disease drug

U.S. health regulators on Friday approved Amicus Therapeutics' Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.

10 Aug 2018

German stocks - Factors to watch on August 9

FRANKFURT/BERLIN, Aug 9 The following are some of the factors that may move German stocks on Thursday:

09 Aug 2018

More drugmakers build Brexit stockpiles as EU agency faces exodus

PARIS/ZURICH/LONDON Sanofi and Novartis said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out of the European Union without a deal. | Video

01 Aug 2018

Sanofi has been stockpiling drugs for no-deal Brexit - WSJ

French drugmaker Sanofi has been making drug-shortage contingency plans for more than a year to prepare for Britain and the European Union failing to reach a Brexit transition deal, the Wall Street Journal reported on Tuesday, citing a source. | Video

01 Aug 2018

More drugmakers build Brexit stockpiles as EU agency faces exodus

PARIS/ZURICH/LONDON Sanofi and Novartis said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out of the European Union without a deal.

01 Aug 2018

Sanofi stockpiling in UK in case of Brexit no-deal - statement

PARIS, Aug 1 Sanofi on Wednesday said it had made arrangements for additional warehouse capacity in Britain to stockpile products, as it makes contingency plans for a no-deal in Brexit negotiations.

01 Aug 2018

Sanofi has been stockpiling drugs for no-deal Brexit: WSJ

French drugmaker Sanofi has been making drug-shortage contingency plans for more than a year to prepare for Britain and the European Union failing to reach a Brexit transition deal, the Wall Street Journal reported on Tuesday, citing a source.

31 Jul 2018

Earnings vs. Estimates